Abbott Laboratories ABT
NYSE ABT
$105.25 -0.27 (-0.26%)
At close: Sep 9, 2026 · 4:00 PM EDT

Abbott Laboratories (ABT) Revenue Growth (3y) (2012 - 2026)

Analysis

Abbott Laboratories (ABT) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 8.07%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 18.10%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 8.20%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 9.66%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 14.78%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 10.83%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 4.73%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 14.51%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 8.05%
10 Zimmer Biomet Holdings 18.70 Bn 18.30 Bn 1.54 Bn 5.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.07%
Mar 31, 2026 4.63%
Dec 31, 2025 4.33%
Sep 30, 2025 2.98%
Jun 30, 2025 -0.34%
Mar 31, 2025 -4.51%
Dec 31, 2024 -1.46%
Sep 30, 2024 -0.90%
Jun 30, 2024 0.50%
Mar 31, 2024 -1.59%
Dec 31, 2023 -1.45%
Sep 30, 2023 4.64%
Jun 30, 2023 10.84%
Mar 31, 2023 8.05%
Dec 31, 2022 6.67%
Sep 30, 2022 8.83%
Jun 30, 2022 12.16%
Mar 31, 2022 16.44%
Dec 31, 2021 13.88%
Sep 30, 2021 12.59%